ABOUT LIFEX

Together, we build healthier lives.

LifeX (formerly Humanscape Inc.), the operator of the Bomee brand (formerly Momitalk), focuses on providing digital healthcare services that solve unmet needs across the entire human life cycle.

Our History

2016 – 2018

Humanscape Inc. established. Secured Series A from major Korean investors.

2019 – 2020

Launched Momitalk (pregnancy & parenting platform) and Rarenote (rare disease & cancer patient platform).

2021 – 2022

Closed Series B ($9.3M). Obtained top-tier medical security certifications. Established U.S. subsidiary in Los Angeles.

2023 – 2024

Closed Series C ($15.4M). Forged strategic global Patient Access Program (PAP) partnerships with AstraZeneca, Novartis, and Sanofi.

2025

Surpassed 1,000 partner clinics globally. Launched Momitalk in the U.S., Indonesia, and Vietnam.

2026

Renamed Humanscape Inc. to LifeX Inc. and rebranded the global pregnancy platform to Bomee. Demonstrated long-term business sustainability.

A platform trusted across 4 countries.

Proven by 8 years of global service stability with zero critical incidents.

🇺🇸

United States

300+ clinics & studios

46K Monthly Active Moms

🇰🇷

Korea

600+ OB-GYN clinics

580K Monthly Active Moms

🇮🇩

Indonesia

388 hospitals

58K Monthly Active Moms

🇻🇳

Vietnam

387 hospitals

52K Monthly Active Moms

Our achievements

Met relevant regulations globally.

Recognized by our partners.

CERTIFICATIONS

HIPAA Compliant
AWS Healthcare Partner
ISO 27001
ISMS (Korea)

42 patents and 59 trademarks across Korea, U.S., Japan, China, EU, and Southeast Asia.

Investors & Partners

INVESTORS

Korea Investment Partners
Naver
Green Cross Holdings
KB Securities
Hanwha Asset Management
Korea Development Bank
Daewoong Investment
Asiana Venture Capital
Nau IB Capital
CareLabs

PHARMA PARTNERS

AstraZeneca
Novartis
Sanofi

HEALTHCARE PARTNERS

GE Healthcare
Kakao

HOSPITAL & RESEARCH PARTNERS

Seoul National University Hospital
Asan Medical Center
40+ Korean tertiary hospitals
Korean Foundation for Rare Disease + 80 patient orgs

Recognition

2023
Minister of Health and Welfare Commendation for Healthcare Technology Innovation (Korean Government)
2024
Presidential Commendation for Venture Entrepreneurship (Korean Government)
2025
Korea Excellent Patent Award, 16th Annual (Korea Times)
2026
Minister of Science and ICT (Deputy Prime Minister) Commendation for Information Culture Contribution — recognizing LifeX's role in closing the digital divide and fostering healthy digital adoption in the pregnancy/parenting and rare-disease communities (Korean Government)